Childhood and adolescent cancer survival: a period analysis of data from the Canadian Cancer Registry
- PMID: 17616390
- DOI: 10.1016/j.ejca.2007.05.014
Childhood and adolescent cancer survival: a period analysis of data from the Canadian Cancer Registry
Abstract
This study provides up-to-date estimates of childhood and adolescent (ages 0-19) cancer survival in Canada using data from the Canadian Cancer Registry (CCR). Cases were classified according to the third edition of the International Classification of Childhood Cancer classification scheme. Follow-up for vital status was determined through record linkage to the Canadian Mortality Data Base, and from information reported by provincial/territorial cancer registries. Observed survival proportions (OSPs) were based on period analysis (1999-2003). The 1-, 3- and 5-year OSPs for all cancers combined were 92%, 85% and 82%, respectively. Among diagnostic groups, five-year survival estimates were highest for retinoblastoma (99%), carcinomas and other malignant epithelial neoplasms and malignant melanomas (91%) and for renal tumours (91%); they were poorest for hepatic tumours (68%) and for malignant bone tumours (68%). Survival for childhood and adolescent cancer in Canada has improved substantially since last reported.
Similar articles
-
Pilot test for linking population-based cancer registries with CCG/POG pediatric registries.J Ky Med Assoc. 2002 May;100(5):195-9. J Ky Med Assoc. 2002. PMID: 12040910
-
An empirical evaluation of period survival analysis using data from the Canadian Cancer Registry.Ann Epidemiol. 2006 Mar;16(3):191-6. doi: 10.1016/j.annepidem.2005.02.017. Epub 2005 Aug 15. Ann Epidemiol. 2006. PMID: 16099673
-
Survival analysis of childhood tumours: data from the Italian cancer registries.Epidemiol Prev. 2001;25(3 Suppl):347-53. Epidemiol Prev. 2001. PMID: 11695200 English, Italian.
-
Quality, comparability and methods of analysis of data on childhood cancer in Europe (1978-1997): report from the Automated Childhood Cancer Information System project.Eur J Cancer. 2006 Sep;42(13):1915-51. doi: 10.1016/j.ejca.2006.05.007. Eur J Cancer. 2006. PMID: 16919762 Review.
-
Epidemiology of childhood cancer in India.Indian J Cancer. 2009 Oct-Dec;46(4):264-73. doi: 10.4103/0019-509X.55546. Indian J Cancer. 2009. PMID: 19749456 Review.
Cited by
-
The emerging era of pharmacogenomics: current successes, future potential, and challenges.Clin Genet. 2014 Jul;86(1):21-8. doi: 10.1111/cge.12392. Epub 2014 May 9. Clin Genet. 2014. PMID: 24684508 Free PMC article. Review.
-
Promoting an ethic of engagement in pediatric palliative care research.BMC Palliat Care. 2015 Oct 16;14:50. doi: 10.1186/s12904-015-0048-5. BMC Palliat Care. 2015. PMID: 26474573 Free PMC article.
-
Drugs Metabolism-Related Genes Variants Impact on Anthracycline-Based Chemotherapy Induced Subclinical Cardiotoxicity in Breast Cancer Patients.Int J Mol Sci. 2025 Apr 25;26(9):4051. doi: 10.3390/ijms26094051. Int J Mol Sci. 2025. PMID: 40362292 Free PMC article.
-
Worldwide Trends in Survival From Common Childhood Brain Tumors: A Systematic Review.J Glob Oncol. 2019 Oct;5:1-25. doi: 10.1200/JGO.19.00140. J Glob Oncol. 2019. PMID: 31682549 Free PMC article.
-
Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity.Br J Clin Pharmacol. 2016 Sep;82(3):683-95. doi: 10.1111/bcp.13008. Epub 2016 Jun 30. Br J Clin Pharmacol. 2016. PMID: 27197003 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources